Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine 3% Gel vs Tetracaine 0.5% in Phacoemulsification
NCT04685538Phase 3Completed
- Sponsor
- Sintetica
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, single-blind trial of chloroprocaine hydrochloride in cataract (2 arms), sponsored by Sintetica. Primary endpoint: Number of Participants in Each Treatment Group With a Successful Surface Anesthesia. Started Sep 2020; status: completed.
02
Drugs
chloroprocaine hydrochloride
03
Conditions
cataract
Beyond the preview
Go deeper on NCT04685538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04685538.